The only approved gene therapy for RP today targets a single gene RPE65, which accounts for just 1% to 2% of the total RP patient population. We believe OCU400 has significantly wider commercial ...
WiseTech Global Limited ( WIGBY) Q2 2026 Earnings Call February 24, 2026 6:00 PM EST Thank you for standing by, and welcome to the WiseTech Global Limited First Half 2026 Results. [Operator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results